You are here: Industry Insights > launch

News List

Launch of Anticancer Agent Halaven in China firstwordpharma
January 11, 2020
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has launched the in-house developed anticancer agent Halaven(R) (generic name: eribulin mesylate) in China.
Precision NanoSystems to Launch the Revolutionary Ignite biospectrumasia
October 09, 2019
Ignite enables rapid benchtop scale development of nanoparticle based RNA, DNA, CRISPR, small molecule and protein therapeutics.
Eisai launches antimicrobial wet wipes biospectrumasia
September 08, 2019
Eisai Co., Ltd. has launched Etak® Antimicrobial Wet Wipes (classified as miscellaneous goods) containing long-acting antimicrobial agent Etak® at pharmacies and drugstores countrywide.
Ping An Good Doctor launches strategic product biospectrumasia
August 15, 2019
The signing amount of the "private doctor" exceeded 300 million yuan on the first day
Harrow Health Announces Launch of Mayfield Pharmaceuticals americanpharmaceuticalreview
August 01, 2019
Harrow Health has filed a Form 8-K with the Securities and Exchange Commission containing a corporate presentation for its subsidiary, Mayfield Pharmaceuticals.
Dermatix launches new product as acne scarring solution biospectrumasia
July 23, 2019
Formulating with Niacinamide (Vitamin B3), Alpha Hydroxy Acids (AHAs) and antioxidants
Sandoz launches oncology generic gefitinib in 13 EU countries biospectrumasia
July 13, 2019
Sandoz gefitinib indicated for adult patients with locally advanced or metastatic non-small cell lung cancer with activating mutations of EGFR-TK
Gilead Sciences announces launch of Asia Pacific Rainbow Grant 2019 biospectrumasia
July 04, 2019
Grant program invites applications from HIV-Focused Community-Based organizations in the Asia Pacific region
Dr. Reddy's Announces Launch of Carboprost Tromethamine Injection americanpharmaceuticalreview
July 04, 2019
Dr. Reddy’s announced the launch of Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL) Single-dose Vial, a therapeutic equivalent generic version of Hemabate® injection, 250 mcg/mL, approved by the U.S. Food and Drug Administration (FDA).
NIH launches large TB prevention trial biospectrumasia
June 28, 2019
A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis (MDR-TB) has begun. The study is comparing the safety and efficacy of a new MDR-TB drug, delamanid, with the decades-old TB dru

Previous page 1 2 3 Next page